Bing Wu

6PUBLICATIONS
15CO-AUTHORS
Innate immunityAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2026
RAS P21 Protein Activator 3 finetunes Type I immunity by limiting HCK-mediated STAT4 phosphorylation.

|Aug 19, 2026
Unconventional role of hydroxymethylglutaryl-CoA synthase 1 in driving pathogenic TH17 cell immunity and autoimmune diseases.

|Apr 29, 2026
Cytochrome P450 1B1 directs pathogenic Th17 cell generation and autoimmune disease by fine-tuning redox homeostasis and mitochondrial integrity.

|Nov 23, 2025
Fructose intake driven glycolysis-ROS-EGFR axis specifically promotes the generation and pathogenicity of Th17 cells.

Xiaoyu Liu, Wenhao Hu, Jie Sun

|Oct 24, 2024
METTL3 governs thymocyte development and thymic involution by regulating ferroptosis.

Huiru Jing, Jiayu Song, Jie Sun

|Jun 24, 2022
Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.

Nazanin Kiapour, Bing Wu, Yan Wang

Pageof 1

Frequent Collaborators

2 joint publications

Wenhao Hu

2 joint publications

Jie Sun

1 joint publications

Nazanin Kiapour

1 joint publications

Yan Wang